, Wushishi F, Pandha H. Increased time to progression and sustained PSA velocity responses in a Phase II trial in advanced metastatic prostate cancer following treatment with ONY-P1, an allogeneic whole cell vaccine. - Dalgleish,A.G.; Quatan,N.; Michael,A. (J Clin Oncol, 2005)